BKG-PHARMA ApS: Financial statements 2016
CVR: 27959350
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity in the 2016 report amounted to DKK -2,682,678.
- Gross Profit
- DKK -616,406
- Profit/Loss
- DKK -18,025,433
- Equity
- DKK -2,682,678
- Total Assets
- DKK 315,632
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -616 t. | -18 mio. | -2.7 mio. | - |
| 2015 | - | -715 t. | -95 t. | 15.3 mio. | - |
| 2014 | - | -28 t. | -65 t. | 14.5 mio. | - |
| 2013 | - | 938 t. | 792 t. | 14.5 mio. | - |
| 2012 | - | 837 t. | 535 t. | 13.8 mio. | - |
Official annual report
Find more companies like BKG-PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
BKG-PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -715,177, and the net result was DKK -94,523.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004. The company has been dissolved on 27 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity in the 2016 report amounted to DKK -2,682,678.